Omid Hamid Honors Jeffrey Weber’s Legacy in Cancer Immunotherapy
Jeffrey Weber and Omid Hamid

Omid Hamid Honors Jeffrey Weber’s Legacy in Cancer Immunotherapy

Omid Hamid, Chief of Research and Immuno-Oncology at The Angeles Clinic and Research Institute, a Cedars-Sinai affiliate, shared on X:

“As we reflect on the Moderna adjuvant vaccine data, I wanted to remind everyone across ESMO, SITC and ASCO of the force that was Jeffrey W. Weber.

We will all feel his presence as the data are presented.

A true mentor, leader and friend.”

Omid Hamid Honors Jeffrey Weber’s Legacy in Cancer Immunotherapy

Other articles about Cancer Vaccines on OncoDaily.